论文部分内容阅读
目的观察无创正压通气在重症支气管哮喘患者治疗中的临床价值。方法选取于我院就诊的70例重症支气管哮喘患者,随机分为观察组和对照组,对照组给予常规支气管哮喘治疗,观察组在常规治疗的基础上给予无创正压通气治疗。观察两组患者的总体治愈率、有创机械通气率、生化指标好转情况。结果观察组患者的总体治愈率高于对照组,差异具有统计学意义(P<0.05),观察组患者有创机械通气率低于对照组,差异具有统计学意义(P<0.05),观察组患者生化指标好转情况优于对照组,差异具有统计学意义(P<0.05)。结论给予重症支气管哮喘患者无创正压通气治疗有助于改善氧供,促进二氧化碳的排出,提高临床治愈率,并降低患者有创机械通气率。
Objective To observe the clinical value of non-invasive positive pressure ventilation in the treatment of patients with severe bronchial asthma. Methods Seventy patients with severe bronchial asthma treated in our hospital were randomly divided into observation group and control group. The control group was given conventional bronchial asthma. The observation group was given noninvasive positive pressure ventilation on the basis of routine treatment. Observe the overall cure rate of two groups of patients, invasive mechanical ventilation rate, biochemical indicators improved. Results The overall curative rate of the observation group was higher than that of the control group (P <0.05). The mechanical ventilation rate of the observation group was lower than that of the control group, the difference was statistically significant (P <0.05) The improvement of biochemical indexes of patients was better than that of control group, the difference was statistically significant (P <0.05). Conclusion Noninvasive positive pressure ventilation in patients with severe bronchial asthma can improve the oxygen supply, promote the discharge of carbon dioxide, improve the clinical cure rate, and reduce the invasive mechanical ventilation rate.